Safety and Efficacy of AGN201781 in Neuropathic Pain

Status:
Terminated

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

This study will explore the safety and efficacy of AGN201781 in patients with postherpetic neuralgia or post-traumatic peripheral neuralgia

Phase 2

Allergan